Page last updated: 2024-08-25

ljc 10627 and Inflammation

ljc 10627 has been researched along with Inflammation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, Y; Hasegawa, H; Imamura, Y; Izumikawa, K; Kakeya, H; Kaku, N; Kohno, S; Migiyama, Y; Miyazaki, T; Morinaga, Y; Nagaoka, K; Nakamura, S; Yamada, K; Yanagihara, K; Yasuoka, A	1

Other Studies

1 other study(ies) available for ljc 10627 and Inflammation

Article	Year
In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa. International journal of antimicrobial agents, 2013, Volume: 42, Issue:3 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Bronchoalveolar Lavage Fluid; Cytokines; Drug Therapy, Combination; Inflammation; Lung; Maleates; Mice; Microbial Sensitivity Tests; Neutrophils; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Survival; Thienamycins; Treatment Outcome	2013

Article

Year

In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa.

International journal of antimicrobial agents, 2013, Volume: 42, Issue:3

Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Bronchoalveolar Lavage Fluid; Cytokines; Drug Therapy, Combination; Inflammation; Lung; Maleates; Mice; Microbial Sensitivity Tests; Neutrophils; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Survival; Thienamycins; Treatment Outcome

2013